How has been the historical performance of Balmer Lawrie?

Answer:The historical performance of Balmer Lawrie shows a steady growth in net sales and profits over the years, with net sales reaching 2,515.64 Cr in March 2025, up from 2,339.23 Cr in March 2024 and 2,321.48 Cr in March 2023. The total operating income also reflects this upward trend, increasing to 2,515.64 Cr in March 2025 from 2,339.23 Cr in March 2024. Operating profit, excluding other income, rose to 312.58 Cr in March 2025, compared to 304.67 Cr in the previous year, while profit after tax was 194.82 Cr, slightly down from 199.31 Cr in March 2024. The consolidated net profit for March 2025 was 265.96 Cr, an increase from 239.76 Cr in March 2024. The company's total assets grew to 3,039.89 Cr in March 2025, up from 2,873.11 Cr in March 2024, indicating a solid asset base. However, total liabilities also increased to 3,039.89 Cr in March 2025 from 2,873.11 Cr in March 2024, reflecting a rise in both long-term borrowings and current liabilities. Cash flow from operating activities decreased to 156.00 Cr in March 2025 from 274.00 Cr in March 2024, contributing to a net cash outflow of 9.00 Cr in March 2025.

Breakdown:
Balmer Lawrie's financial performance over the years shows a consistent increase in net sales, which reached 2,515.64 Cr in March 2025, marking a growth from 2,339.23 Cr in March 2024. This growth in sales is mirrored in the total operating income, which also rose to 2,515.64 Cr. Operating profit, excluding other income, increased to 312.58 Cr, while profit after tax saw a slight decline to 194.82 Cr. The consolidated net profit, however, increased to 265.96 Cr, indicating a positive trend in profitability. On the balance sheet, total assets grew to 3,039.89 Cr, alongside a rise in total liabilities to the same figure, suggesting a proportional increase in debt. Cash flow from operating activities decreased significantly to 156.00 Cr, contributing to a net cash outflow of 9.00 Cr, highlighting potential liquidity concerns despite the overall growth in sales and profits.